Developing a tissue‐engineered model of the human bronchiole

Scientists are always looking for new tools to better mimic human anatomy and physiology, especially to study chronic respiratory disease. Airway remodelling is a predominant feature in asthma and occurs in conjunction with chronic airway inflammation. Both the inflammatory and repair processes alter the airway wall which is marked by anatomical, physiological and functional changes. A tissue‐engineered model of bronchiole remodelling presents a novel approach to investigating the initiation and progression of airway remodelling. By developing a unique bioreactor system, cylindrical‐shaped bronchioles constructed from well‐characterized human lung primary cells have been engineered and examined with a much greater control over experimental variables. We have grown human bronchioles composed of fibroblasts, airway smooth muscle cells, small airway epithelial cells and extracellular matrices. The various cell types are in close proximity to one another for cell–cell signalling and matrix interactions. The cylindrical geometry of the tissue applies radial distension for mechanotransduction and the air interface provides a natural environment for the epithelial cells. Optimal cell density, extracellular matrix concentration and media composition were determined. Immunohistochemistry verified bronchiole phenotypic stability. Quiescence was gauged by protein expression which verified a change in phenotype after the initial fabrication stage and implementation of the air interface. A fabrication timeline was devised for repeatable bronchiole fabrication and to understand tissue contraction and cell‐seeding duration. The stability of the bronchiole structures and their cellular composition lends these bronchioles to study cell–cell interactions and remodelling events while maintaining in vivo geometrical dimensions and relationships. Copyright © 2010 John Wiley & Sons, Ltd.

[1]  D. Broide,et al.  Cytokines and growth factors in airway remodeling in asthma. , 2007, Current opinion in immunology.

[2]  J. Fredberg,et al.  Biophysical basis for airway hyperresponsiveness. , 2007, Canadian journal of physiology and pharmacology.

[3]  R. Medzhitov,et al.  Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines. , 2007, Current opinion in immunology.

[4]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[5]  J. Burgess,et al.  Airway smooth muscle—its relationship to the extracellular matrix , 2003, Respiratory Physiology & Neurobiology.

[6]  J. Elias,et al.  Interleukin-13 and leukotrienes: an intersection of pathogenetic schema. , 2003, American journal of respiratory cell and molecular biology.

[7]  C. Page,et al.  Airway remodelling in asthma , 2002 .

[8]  D. Tschumperlin,et al.  Mechanical stimuli to airway remodeling. , 2001, American journal of respiratory and critical care medicine.

[9]  Rakesh K. Kumar,et al.  Understanding airway wall remodeling in asthma: a basis for improvements in therapy? , 2001, Pharmacology & therapeutics.

[10]  J. Renauld New insights into the role of cytokines in asthma , 2001, Journal of clinical pathology.

[11]  P. Woodruff,et al.  Asthma: prevalence, pathogenesis, and prospects for novel therapies. , 2001, JAMA.

[12]  R D Kamm,et al.  Mechanical stress is communicated between different cell types to elicit matrix remodeling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Koo,et al.  Regulation of mucous differentiation and mucin gene expression in the tracheobronchial epithelium. , 2001, Toxicology.

[14]  T. Lee,et al.  Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. , 2000, American journal of respiratory cell and molecular biology.

[15]  A. Tanswell,et al.  Mechanical force-induced signal transduction in lung cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[16]  S. Holgate,et al.  Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[17]  L. Cohn,et al.  IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. , 1998, Journal of immunology.

[18]  J. Bousquet,et al.  Growth factors in asthma. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[19]  S. Hirst,et al.  Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. , 1996, The European respiratory journal.

[20]  A. Brody,et al.  Cytokine-binding proteins in the lung. , 1995, The American journal of physiology.

[21]  E. Zelazny,et al.  IL-1 beta and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. , 1995, Journal of applied physiology.

[22]  T. Harris,et al.  MITOGENIC ACTIONS OF ENDOTHELIN‐1 AND EPIDERMAL GROWTH FACTOR IN CULTURED AIRWAY SMOOTH MUSCLE , 1994, Clinical and experimental pharmacology & physiology.

[23]  A. Verma,et al.  The mechanism of the inhibition of squamous differentiation of rat tracheal 2C5 cells by retinoic acid. , 1994, Carcinogenesis.

[24]  M. Grunstein,et al.  Role and mechanism of thromboxane-induced proliferation of cultured airway smooth muscle cells. , 1992, The American journal of physiology.

[25]  S. Wenzel,et al.  Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma. , 2004, The American journal of pathology.

[26]  S. George,et al.  Expression of matrix proteins in an in vitro model of airway remodeling in asthma. , 2003, Allergy and asthma proceedings.

[27]  W. Henderson,et al.  Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. , 2003, The Journal of allergy and clinical immunology.

[28]  I. Grzelewska-Rzymowska,et al.  [Airway remodeling in asthma]. , 2003, Pneumonologia i alergologia polska.

[29]  J. Shute Growth factor-extracellular matrix interactions in bronchial tissue in asthma , 2001 .

[30]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[31]  G. Grünig Requirement for IL-13 independently of IL-4 in experimental asthma , 1998 .